Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (10): 1188-1194.doi: 10.12092/j.issn.1009-2501.2020.10.015

Previous Articles     Next Articles

Pharmacological activities and clinical application of yuanhuacine

WANG Yujue1, SHANG Xinyue1,2, YAO Guodong1,2,3   

  1. 1 School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China; 2 Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Shenyang 110016, Liaoning, China; 3 Jiangsu Kanion Pharmaceutical Company Ltd, Lianyungang 222001, Jiangsu, China
  • Received:2020-06-03 Revised:2020-07-21 Online:2020-10-26 Published:2020-11-03

Abstract: Yuanhuacine is a daphne-type diterpene isolated from Daphne genkwa. It is also isolated from the plant of Daphne and Euphorbia. With the further research on yuanhuacine, it has been found that yuanhuacine has strong anti-tumor activity, and it also exhibits significant anti-virus, anti-inflammatory, neuroprotective and anti-fertility activities. Yuanhuacine can enter various tissues with the blood, and pass through the blood-brain barrier. The bioavailability of yuanhuacine is good, which has potential therapeutic significance for the lesions of all tissues. However, the researches on yuanhuacine mainly focus on the preclinical research and yuanhuacine is only used to induce labor clinically. The purpose of this study is to systematically summarize and analyze the pharmacological activity, drug metabolism in vivo, and clinical application of yuanhuacine, so as to provide a theoretical basis for its development and application.

Key words: yuanhuacine, pharmacological activities, clinical application

CLC Number: